Frontiers in Anti-Infective Drug Discovery.
Saved in:
| Author / Creator: | Atta-ur-Rehman. |
|---|---|
| Imprint: | Sharjah : Bentham Science Publishers, 2018. |
| Description: | 1 online resource (293 pages) |
| Language: | English |
| Series: | Frontiers in Anti-Infective Drug Discovery Ser. ; v. 7 Frontiers in Anti-Infective Drug Discovery Ser. |
| Subject: | |
| Format: | E-Resource Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/12351670 |
MARC
| LEADER | 00000cam a2200000Mu 4500 | ||
|---|---|---|---|
| 001 | 12351670 | ||
| 005 | 20210426223014.4 | ||
| 006 | m o d | ||
| 007 | cr |n|---||||| | ||
| 008 | 180623s2018 xx o 000 0 eng d | ||
| 019 | |a 1040624054 | ||
| 020 | |a 9781681085623 | ||
| 020 | |a 1681085623 | ||
| 035 | |a (OCoLC)1041918857 |z (OCoLC)1040624054 | ||
| 040 | |a EBLCP |b eng |e pn |c EBLCP |d OCLCQ |d K6U |d OCLCO |d OCLCF |d YDX |d N$T |d UKAHL | ||
| 049 | |a MAIN | ||
| 050 | 4 | |a RM267 | |
| 066 | |c (S | ||
| 100 | 1 | |a Atta-ur-Rehman. | |
| 245 | 1 | 0 | |a Frontiers in Anti-Infective Drug Discovery. |
| 260 | |a Sharjah : |b Bentham Science Publishers, |c 2018. | ||
| 300 | |a 1 online resource (293 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Frontiers in Anti-Infective Drug Discovery Ser. ; |v v. 7 | |
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |6 880-01 |a Intro; CONTENTS; PREFACE; List of Contributors; The Role of the Microbiota in the Genesis of Gastrointestinal Cancers; Edda Russo and Amedeo Amedei*; 1. INTRODUCTION; 2. THE HUMAN MICROBIOTA; 3. THE GASTROINTESTINAL MICROBIOTA; 3.1. Composition and Activities; 3.2. Gastro-Intestinal Colonization by the Microbiota and Selection; 3.3. The Human Microbiome Project; 3.4. Gut Enterotypes; 4. THE ROLE OF MICROBIOTA IN TUMOR DEVELOPMENT; 4.1. Proposed Models for Microbiota-induced Carcinogenesis; 4.2. Antibacteria-Specific Immune Response and Cancer Promotion; 5. MICROBIOTA AND GI CANCERS. | |
| 505 | 8 | |a 5.1. Gut Bacteria Dysbiosis Associated with GI Cancer5.2. Microbiota Involvement in Gastric and Esophageal Cancers, the Role of Helicobacter pylori; 5.3. Microbiota Involvement in Colorectal Cancer; 5.3.1. Specific Gut Bacteria and CRC; 5.3.2. Bacteria Metabolites and CRC; 5.4. Gallbladder Cancer; 5.5. Liver Cancer; 5.6. Pancreatic Cancer; 6. BENEFICIAL ACTIVITIES OF GUT MICROBIOTA; 6.1. Antitumorigenic Impact of Microbiota; 6.2. Manipulating the Microbiota for Cancer Therapy; 7. CONCLUSION; CONSENT FOR PUBLICATION; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; REFERENCES. | |
| 505 | 8 | |a Towards Host Cell-Targeting Therapies to Treat Dengue Virus InfectionsCybele C. García1,2, Verónica M. Quintana1, Viviana Castilla1 and Elsa B. Damonte1,2,*; INTRODUCTION; INTERACTION WITH CELL RECEPTORS; ENDOCYTOSIS AND FUSION FOR UNCOATING; LIPID METABOLISM; PROTEIN TRANSLATION; UNFOLDED PROTEIN RESPONSE; UBIQUITIN PROTEASOME PATHWAY; NUCLEOTIDE METABOLISM; KINASES; Mitogen-activated Protein Kinases; ERK Pathway; JNK Pathway; p38 Pathway; Other Kinases; Src, Ab1 and Fyn Kinases; AP2-associated Protein Kinase 1 and Cyclin G-associated Kinase; Phosphatidylinositol 3 Kinase/Akt Pathway. | |
| 505 | 8 | |a SCREENING STRATEGIES TO CHARACTERISE PLANT PRODUCTS WITH POTENTIAL RESISTANCE MODIFYING ACTIVITYASSESSMENT OF SYNERGISTIC INTERACTION BETWEEN ANTIBIOTIC AND A PHYTOCOMPOUND AGAINST RESISTANT BACTERIA; Fractional Inhibitory Concentration Index (FICI); Modulation Factor (MF); Isobologram; SEARCH FOR PLANT-DERIVED SECONDARY METABOLITES WITH PROSPECTIVE RESISTANCE MODIFYING ACTIVITY; Key Early Studies Pertaining to Discovery of RMAs from Plants; Recent Studies; PHYTOCHEMICALS AND RELEVANT BACTERIAL RESISTANCE MECHANISMS; Efflux Pump Inhibition; Alteration of Bacterial Cell Membrane Permeability. | |
| 500 | |a Protein Synthesis Inhibition. | ||
| 650 | 0 | |a Anti-infective agents. |0 http://id.loc.gov/authorities/subjects/sh85005613 | |
| 650 | 0 | |a Communicable diseases. |0 http://id.loc.gov/authorities/subjects/sh85029015 | |
| 650 | 7 | |a Anti-infective agents. |2 fast |0 (OCoLC)fst00810345 | |
| 650 | 7 | |a Communicable diseases. |2 fast |0 (OCoLC)fst00869883 | |
| 655 | 4 | |a Electronic books. | |
| 700 | 1 | |a Chaudhry, Iqbal. | |
| 776 | 0 | 8 | |i Print version: |a Atta-ur-Rehman. |t Frontiers in Anti-Infective Drug Discovery: Volume 7. |d Sharjah : Bentham Science Publishers, ©2018 |z 9781681085630 |
| 830 | 0 | |a Frontiers in Anti-Infective Drug Discovery Ser. | |
| 880 | 8 | |6 505-01/(S |a PROTEIN PROCESSINGEndoplasmic Reticulum α-glucosidases; Furin; Endoplasmic Reticulum Associated Signal Peptidase; INNATE ANTIVIRAL RESPONSE; Interferon Activity; Cell-intrinsic Restriction Factors; CONCLUDING REMARKS; CONSENT FOR PUBLICATION; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; REFERENCES; Synergistic Interaction Between Plant Products and Antibiotics Against Potential Pathogenic Bacteria; Banasri Hazra1,*, Sutapa Biswas Majee2, Subhalakshmi Ghosh1 and Dhruti Avlani2; INTRODUCTION; BACTERIAL RESISTANCE TOWARDS CLINICAL ANTIBIOTICS; Background; Mechanisms and Associated Factors. | |
| 903 | |a HeVa | ||
| 929 | |a oclccm | ||
| 999 | f | f | |i b7db857d-d080-50fc-a02f-24e25e287783 |s a50713b5-a774-55b1-bc32-3c2e3e301ef7 |
| 928 | |t Library of Congress classification |a RM267 |l Online |c UC-FullText |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=1828652 |z eBooks on EBSCOhost |g ebooks |i 12463967 | ||